Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark F McCarty

Showing results (111-120 of 193) with videos related to

Pageof 20
Sort By:
Open Heart|August 23, 2016
Lauric acid-rich medium-chain triglycerides can substitute for other oils in cooking applications and may have limited pathogenicityMark F McCarty, James J DiNicolantonio
The British Journal of Nutrition|October 1, 2014
Are organically grown foods safer and more healthful than conventionally grown foods?Mark F McCarty, James J DiNicolantonio
Open Heart|October 22, 2014
The cardiometabolic benefits of glycine: Is glycine an 'antidote' to dietary fructose?Mark F McCarty, James J DiNicolantonio
Open Heart|February 17, 2015
Acarbose, lente carbohydrate, and prebiotics promote metabolic health and longevity by stimulating intestinal production of GLP-1Mark F McCarty, James J DiNicolantonio
Medical Hypotheses|May 11, 2020
Targeting Casein kinase 2 with quercetin or enzymatically modified isoquercitrin as a strategy for boosting the type 1 interferon response to viruses and promoting cardiovascular healthJames J DiNicolantonio, Mark F McCarty
Healthcare (Basel, Switzerland)|January 21, 2022
Maintaining Effective Beta Cell Function in the Face of Metabolic Syndrome-Associated Glucolipotoxicity-Nutraceutical OptionsMark F McCarty, James J DiNicolantonio
Age (Dordrecht, Netherlands)|September 13, 2015
An increased need for dietary cysteine in support of glutathione synthesis may underlie the increased risk for mortality associated with low protein intake in the elderlyMark F McCarty, James J DiNicolantonio
Current Pharmaceutical Design|July 25, 2018
Co-administration of Phycocyanobilin and/or Phase 2-Inducer Nutraceuticals for Prevention of Opiate ToleranceMark F McCarty, Simon Iloki-Assanga
Nutrition and Cancer|October 2, 2018
Minimizing Membrane Arachidonic Acid Content as a Strategy for Controlling Cancer: A ReviewMark F McCarty, James J DiNicolantonio
Medical Hypotheses|February 16, 2015
The protection conferred by chelation therapy in post-MI diabetics might be replicated by high-dose zinc supplementationMark F McCarty, James J DiNicolantonio
Pageof 20

Showing results (111-120 of 193) with videos related to

Sort By:
Pageof 20
Open Heart|August 23, 2016
Lauric acid-rich medium-chain triglycerides can substitute for other oils in cooking applications and may have limited pathogenicityMark F McCarty, James J DiNicolantonio
The British Journal of Nutrition|October 1, 2014
Are organically grown foods safer and more healthful than conventionally grown foods?Mark F McCarty, James J DiNicolantonio
Open Heart|October 22, 2014
The cardiometabolic benefits of glycine: Is glycine an 'antidote' to dietary fructose?Mark F McCarty, James J DiNicolantonio
Open Heart|February 17, 2015
Acarbose, lente carbohydrate, and prebiotics promote metabolic health and longevity by stimulating intestinal production of GLP-1Mark F McCarty, James J DiNicolantonio
Medical Hypotheses|May 11, 2020
Targeting Casein kinase 2 with quercetin or enzymatically modified isoquercitrin as a strategy for boosting the type 1 interferon response to viruses and promoting cardiovascular healthJames J DiNicolantonio, Mark F McCarty
Healthcare (Basel, Switzerland)|January 21, 2022
Maintaining Effective Beta Cell Function in the Face of Metabolic Syndrome-Associated Glucolipotoxicity-Nutraceutical OptionsMark F McCarty, James J DiNicolantonio
Age (Dordrecht, Netherlands)|September 13, 2015
An increased need for dietary cysteine in support of glutathione synthesis may underlie the increased risk for mortality associated with low protein intake in the elderlyMark F McCarty, James J DiNicolantonio
Current Pharmaceutical Design|July 25, 2018
Co-administration of Phycocyanobilin and/or Phase 2-Inducer Nutraceuticals for Prevention of Opiate ToleranceMark F McCarty, Simon Iloki-Assanga
Nutrition and Cancer|October 2, 2018
Minimizing Membrane Arachidonic Acid Content as a Strategy for Controlling Cancer: A ReviewMark F McCarty, James J DiNicolantonio
Medical Hypotheses|February 16, 2015
The protection conferred by chelation therapy in post-MI diabetics might be replicated by high-dose zinc supplementationMark F McCarty, James J DiNicolantonio
Pageof 20